Alibaba Health Information Technology Limited Stock Shanghai - Hong Kong Stock Connect
Stocks
241
BMG0171K1018
Drug Retailers
OTC Markets Traded| Market Cap | 39.11B 45.67B 5.82B 5.12B 4.83B 4.41B 8.24B 559B 8.3B 57.94B 22.45B 284B 21.86B 21.39B 926B | P/E 2027 * |
18.9x | P/E 2028 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 26.43B 30.86B 3.94B 3.46B 3.26B 2.98B 5.57B 378B 5.61B 39.16B 15.17B 192B 14.78B 14.45B 626B | EV / Sales 2027 * |
0.7x | EV / Sales 2028 * | 0.58x |
| Free-Float |
36.48% | Yield 2027 * |
1.13% | Yield 2028 * | 1.46% |
| 1 day | +0.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
Meng Yue Sheng
DFI | Director of Finance/CFO | 44 | 15/05/2026 |
Hiu Leong Tsui
SEC | Corporate Secretary | - | 12/08/2023 |
Hua Zhang
HRO | Human Resources Officer | - | 01/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CHM | Chairman | 47 | 15/12/2025 |
Yi Fei Huang
BRD | Director/Board Member | 52 | 09/06/2019 |
Jiaojiao Huang
BRD | Director/Board Member | 44 | 15/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.83% | -0.62% | - | - | 5.82B | ||
| -2.01% | -3.31% | -47.95% | -13.91% | 14.56B | ||
| -0.10% | -0.26% | -18.42% | -8.07% | 6.25B | ||
| 0.00% | -7.83% | -56.61% | -39.38% | 5.82B | ||
| -0.05% | -2.95% | -12.69% | -24.30% | 3.99B | ||
| +0.33% | +0.83% | -20.34% | -37.19% | 3.17B | ||
| -2.34% | -4.15% | +1.98% | -30.99% | 2.98B | ||
| +0.28% | +2.76% | -40.91% | -17.44% | 3.01B | ||
| -3.40% | -7.24% | +59.44% | - | 2.65B | ||
| +0.74% | -3.68% | -25.32% | -14.49% | 2.27B | ||
| Average | -0.57% | -1.76% | -17.87% | -23.22% | 4.97B | |
| Weighted average by Cap. | -0.75% | -0.55% | -28.54% | -20.80% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 37.67B 43.98B 5.61B 4.93B 4.65B 4.24B 7.93B 538B 8B 55.8B 21.62B 274B 21.06B 20.6B 892B | 41.53B 48.49B 6.18B 5.44B 5.13B 4.68B 8.75B 594B 8.82B 61.52B 23.84B 302B 23.22B 22.71B 983B |
| Net income | 2.07B 2.42B 308M 271M 256M 233M 436M 29.61B 440M 3.07B 1.19B 15.07B 1.16B 1.13B 49.04B | 2.43B 2.84B 362M 319M 300M 274M 512M 34.76B 516M 3.6B 1.4B 17.69B 1.36B 1.33B 57.57B |
| Net Debt | -12.68B -14.8B -1.89B -1.66B -1.57B -1.43B -2.67B -181B -2.69B -18.78B -7.28B -92.21B -7.09B -6.93B -300B | -15B -17.52B -2.23B -1.96B -1.85B -1.69B -3.16B -214B -3.19B -22.23B -8.61B -109B -8.39B -8.21B -355B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















